Sanjivani Paranteral Ltd
Sanjivani Paranteral Ltd Share Price Today: Live Updates & Key Insights
Get insights on Sanjivani Paranteral Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Sanjivani Paranteral Ltd Share Price Chart
SANJIVPARANT at 10 Jul 2026 05:40 PM Pharmaceuticals
144.00 +0.95(+0.66%)
Lowest Today 143.05
Highest Today 147.45
Today's Open 143.05
Prev. Close 143.05
52 Week High 268.80
52 Week Low 126.00
Sanjivani Paranteral Ltd Fundamentals
Traded Volume: 5,657
Market Cap(Cr): 176.89
Avg Traded Price 146.32
1 Year return -34.34%
Upper Circuit 147.4
Lower Circuit 143.1
P/E TTM 0.00
P/B Ratio 3.632
Traded Value(Cr) 8.15
EPS TTM NaN
Book value/Share 39.390
Dividend Yield 1Y 0.00%
Sanjivani Paranteral Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Sanjivani Paranteral Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Sanjivani Paranteral Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W 0.00%
1M 0.00%
3M 0.00%
1Y -34.34%
YTD 0.00%
Sanjivani Paranteral Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Sanjivani Paranteral Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday N/A
Day Before Yesterday N/A
1W Avg N/A
1M Avg N/A
3M Avg N/A
Sanjivani Paranteral Ltd Technical Details
Sanjivani Paranteral Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 140
Support 2 136
Support 3 132
Pivot Point : 144
Resistance 1 147
Resistance 2 151
Resistance 3 155
Sanjivani Paranteral Ltd Corporate Actions
Sanjivani Paranteral Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Sanjivani Paranteral Ltd’s capital allocation strategies.
All
Ex-Date 19-Sep-2025 Type D Description 0.50/share@5.00% Record Date 19-Sep-2025 Ratio 5.00
Dividends
Announcement Date 19-Sep-2025 Ex Dividend Date 19-Sep-2025 Dividend(%) 5
Bonus
No Bonus has been declared by SANJIVPARANT
Splits
No Split has been declared by SANJIVPARANT
Others
Rights No Rights has been declared by SANJIVPARANT
Sanjivani Paranteral Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Sanjivani Paranteral Ltd with leading peers in the pharmaceuticals & biotechnology sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Sanjivani Paranteral Ltd's relative performance and valuation against major competitors.
Stock Name Kerala Ayurveda Ltd ₹165.75 (+1.59%) M. Cap (Cr) 2.15 1 Yr Return (%) -70.90% P/E (TTM) -12.05 PB Ratio 19.06
Stock Name Achyut Healthcare Ltd ₹8.20 (+0.12%) M. Cap (Cr) 1.98 1 Yr Return (%) +110.26% P/E (TTM) 673.23 PB Ratio 5.65
Stock Name Accretion Nutraveda Ltd ₹259.30 (+4.96%) M. Cap (Cr) 1.88 1 Yr Return (%) NaN% P/E (TTM) 37.04 PB Ratio 5.29
Stock Name Sanjivani Paranteral Ltd ₹144.00 (+0.66%) M. Cap (Cr) 1.77 1 Yr Return (%) -34.34% P/E (TTM) 17.96 PB Ratio 3.67
Stock Name Accretion Pharmaceuticals Ltd ₹157.00 (-2.36%) M. Cap (Cr) 1.75 1 Yr Return (%) NaN% P/E (TTM) 18.05 PB Ratio 3.19
Stock Name Oxygenta Pharmaceutical Ltd ₹48.25 (+4.32%) M. Cap (Cr) 1.78 1 Yr Return (%) -57.68% P/E (TTM) -10.18 PB Ratio -4.19
Stock Name Parnax Lab Ltd ₹142.70 (-1.92%) M. Cap (Cr) 1.64 1 Yr Return (%) +37.34% P/E (TTM) 13.92 PB Ratio 1.72
Sanjivani Paranteral Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Sanjivani Paranteral Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2026 -1.55 Mar 2025 -0.24 Mar 2024 -10.70 Mar 2023 4.68 Mar 2022 8.52
PARTICULARS Investing Activities Mar 2026 -4.47 Mar 2025 -5.81 Mar 2024 -12.21 Mar 2023 -0.99 Mar 2022 -0.67
PARTICULARS Financing Activities Mar 2026 6.54 Mar 2025 6.14 Mar 2024 23.16 Mar 2023 -3.73 Mar 2022 -7.69
PARTICULARS Net Cash Flow Mar 2026 0.52 Mar 2025 0.09 Mar 2024 0.24 Mar 2023 -0.04 Mar 2022 0.16
Sanjivani Paranteral Ltd Shareholding Pattern
This shows the ownership breakdown of Sanjivani Paranteral Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter N/A%
Public N/A%
Other Institutions N/A%
FII N/A%
Mutual Funds N/A%
About Sanjivani Paranteral Ltd
Sanjivani Paranteral Limited is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades. The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun.Incorporated as a Public Limited Company in October, 1994, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The Company is involved in the manufacturing of pharmaceutical medicines. Its products includes oral solids, small volume parenteral and sterile powder formulations.The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan.'96 to part-finance the project.The promoters have received firm inquiries from reputed pharmaceutical companies like Merind, Lupin Laboratories and USV for the first year' production of liquid vials and ampules.During the year 1999-2000, the company has tied-up with India's first ranked pharmaceutical giant Ranbaxy for manufacturing its products.During 2009, the Company acquired a new pharmaceutical manufacturing plant in Uttarakhand. The Company launched two strategic ventures SPL Infusion Pvt. Ltd. in Pune for intravenous (IV) fluids and Alevia Healthcare S.R.O. in Prague, Czech Republic. for nutraceuticals in FY 2024-25. The base business has expanded by launching 15 new formulations, bringing the bringing to approximately 160 products in 2025. The nutraceuticals manufacturing unit in Prague was commissioned in partnership with Alevia Healthcare S.R.O by entering the burgeoning European nutraceutical market, valued at over EUR 70 billion.
Chairman / Executive Director / M D / Promoter
Ashwin Khemka
Registered office 205 P N Khotari Indl Estate, LBS Marg Bhandup (West), Mumbai, Maharashtra, 400078
FAX :91-22-67290900
Background
Incorporation Year 1994
Face Value ₹10.00
Market Lot 1
FAQs on Sanjivani Paranteral Ltd
How to buy Sanjivani Paranteral Ltd shares?
To buy Sanjivani Paranteral Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the market cap of Sanjivani Paranteral Ltd?
The company has a market capitalization of ₹176.89.
What is the PE & PB ratio of Sanjivani Paranteral Ltd?
PE is N/A and PB is 3.632.
What is the Sanjivani Paranteral Ltd dividend for 2025–26?
For the 2025–26 financial year, Sanjivani Paranteral Ltd declared a final dividend of null% per share.